BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16127295)

  • 1. Accumulation of BCL10 at the perinuclear region is required for the BCL10-mediated nuclear factor-kappa B activation.
    Nakamura K; Senda T; Sato K; Mori S; Moriyama M
    Pathobiology; 2005; 72(4):191-202. PubMed ID: 16127295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
    Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
    Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein.
    Woo HN; Hong GS; Jun JI; Cho DH; Choi HW; Lee HJ; Chung CW; Kim IK; Jo DG; Pyo JO; Bertin J; Jung YK
    FEBS Lett; 2004 Dec; 578(3):239-44. PubMed ID: 15637807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.
    Ye H; Dogan A; Karran L; Willis TG; Chen L; Wlodarska I; Dyer MJ; Isaacson PG; Du MQ
    Am J Pathol; 2000 Oct; 157(4):1147-54. PubMed ID: 11021819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
    Oruganti SR; Edin S; Grundström C; Grundström T
    Mol Immunol; 2011 Jul; 48(12-13):1448-60. PubMed ID: 21513986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
    Edin S; Oruganti SR; Grundström C; Grundström T
    Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide activates NF-kappaB by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.
    Bhattacharyya S; Dudeja PK; Tobacman JK
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G784-90. PubMed ID: 18718996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALT lymphoma: many roads lead to nuclear factor-κb activation.
    Du MQ
    Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation. Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus.
    Yeh PY; Kuo SH; Yeh KH; Chuang SE; Hsu CH; Chang WC; Lin HI; Gao M; Cheng AL
    J Biol Chem; 2006 Jan; 281(1):167-75. PubMed ID: 16280327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.
    Gaide O; Martinon F; Micheau O; Bonnet D; Thome M; Tschopp J
    FEBS Lett; 2001 May; 496(2-3):121-7. PubMed ID: 11356195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.